Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer

This trial was designed to assess efficacy and safety of erlotinib with sorafenib in the treatment of patients with advanced pancreatic adenocarcinoma. An exploratory correlative study analyzing pretreatment serum samples using a multivariate protein mass spectrometry-based test (VeriStrat®), previo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cardin, Dana B, Goff, Laura, Li, Chung-I, Shyr, Yu, Winkler, Charles, DeVore, Russell, Schlabach, Larry, Holloway, Melanie, McClanahan, Pam, Meyer, Krista, Grigorieva, Julia, Berlin, Jordan, Chan, Emily
Natura: Artigo
Lingua:Inglês
Pubblicazione: BlackWell Publishing Ltd 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101748/
https://ncbi.nlm.nih.gov/pubmed/24574334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.208
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi